Evdakov, V.A.,
Starodubov, V.I.,
Oleynik, B.A.,
Sharafutdinova, N.Kh.,
Borisova, M.V.,
Plechev, V.V. (2023) in recent decades, and that is
largely associated with control of risk factors and improvement of acute
Zhu, Weiwei,
Luo, Wu,
Han, Jibo,
Zhang, Qiuyan,
Ji, Lijun,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhuang, Zaishou,
Yang, Daona,
Yin, Lina,
Huang, Lijiang,
Liang, Guang (2023) B prior to LPS challenge reduced inflammatory
cell infiltration in lungs, induction of MyD88-pathway
Перспективы эпигенетической иммунотерапии рака почки, -652, -585, -511, -502,
-495, -493, -487
b, -335; повышенная – для miR-1249, -1266, -151a, -211, -2114
Chen, P.,
Yu, Y.,
Su, S.,
Du, Z.,
Cai, B.,
Sun, X.,
Chattipakorn, N.,
Samorodov, A.V.,
Pavlov, V.N.,
Tang, Q.,
Cho, W.-J.,
Liang, G. (2023) in lipopolysaccharide (LPS)-challenged J774A.1
cells. Compounds 19, 20, and 39 potently reduced the release of IL-6
decrease in photoreceptor
cell and retinal pigment epithelium (RPE)
cell density and retinal layer
Sufianov, Albert,
Begliarzade, Sema,
Kudriashov, Valentin,
Beilerli, Aferin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) of diseases and has a potential to be used as a disease marker. Oral squamous
cell carcinoma is one